These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12598432)

  • 21. Utility values associated with diabetic retinopathy in Chennai, India.
    Polack S; Alavi Y; Rachapalle Reddi S; Kulothungan V; Kuper H
    Ophthalmic Epidemiol; 2015 Feb; 22(1):20-7. PubMed ID: 24669801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study.
    Trento M; Passera P; Trevisan M; Schellino F; Sitia E; Albani S; Montanaro M; Bandello F; Scoccianti L; Charrier L; Cavallo F; Porta M
    Acta Diabetol; 2013 Dec; 50(6):873-7. PubMed ID: 23526056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
    Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial adjustment to advanced proliferative diabetic retinopathy.
    Wulsin LR; Jacobson AM; Rand LI
    Diabetes Care; 1993 Aug; 16(8):1061-6. PubMed ID: 8375233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.
    Smith TS; Szetu J; Bourne RR
    Br J Ophthalmol; 2007 Apr; 91(4):415-9. PubMed ID: 17077115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vision-related quality of life and visual outcomes from cataract surgery in patients with vision-threatening diabetic retinopathy: a prospective observational study.
    Zhu B; Ma Y; Lin S; Zou H
    Health Qual Life Outcomes; 2017 Sep; 15(1):175. PubMed ID: 28865457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of quality of life among Taiwanese patients with visual impairment.
    Lin JC; Yu JH
    J Formos Med Assoc; 2012 Oct; 111(10):572-9. PubMed ID: 23089693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL.
    Woodcock A; Bradley C; Plowright R; ffytche T; Kennedy-Martin T; Hirsch A
    Patient Educ Couns; 2004 Jun; 53(3):365-83. PubMed ID: 15186876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of keratoconus in the better eye and the worse eye on vision-related quality of life.
    Sahebjada S; Fenwick EK; Xie J; Snibson GR; Daniell MD; Baird PN
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):412-6. PubMed ID: 24398095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life.
    Gabrielian A; Hariprasad SM; Jager RD; Green JL; Mieler WF
    Eye (Lond); 2010 Jan; 24(1):29-35. PubMed ID: 19325572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
    Aiello LP; Vignati L; Sheetz MJ; Zhi X; Girach A; Davis MD; Wolka AM; Shahri N; Milton RC;
    Retina; 2011 Nov; 31(10):2084-94. PubMed ID: 21862954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vision-related quality of life and locus of control in type 1 diabetes: a multicenter observational study.
    Trento M; Charrier L; Cavallo F; Bertello S; Oleandri S; Donati MC; Rizzo S; Virgili G; Picca G; Bandello F; Lattanzio R; Aragona E; Perilli R; Casati S; Beltramo E; Mazzeo A; Fornengo P; Durando O; Merlo S; Porta M
    Acta Diabetol; 2019 Nov; 56(11):1209-1216. PubMed ID: 31313005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy.
    Scanlon PH; Martin ML; Bailey C; Johnson E; Hykin P; Keightley S
    Diabet Med; 2006 Jan; 23(1):60-6. PubMed ID: 16409567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.
    Kobelt G; Jonsson B; Bergström A; Chen E; Lindén C; Alm A
    Acta Ophthalmol Scand; 2006 Jun; 84(3):363-71. PubMed ID: 16704699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The assessment of disability related to vision performance-based measure in diabetic retinopathy.
    Warrian KJ; Lorenzana LL; Lankaranian D; Dugar J; Wizov SS; Spaeth GL
    Am J Ophthalmol; 2010 May; 149(5):852-60.e1. PubMed ID: 20399929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
    Scanlon PH; Foy C; Chen FK
    Br J Ophthalmol; 2008 Jun; 92(6):775-8. PubMed ID: 18356262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.